10-Q · May 15, 2026
Aterian, Inc. reported a drastic decrease in revenue of 72% in Q1 2026 compared to Q1 2025, falling to $18 thousand primarily due to reduced consumer demand amid macroeconomic pressures. The company is undergoing…
Earnings analysis · 10-Q
Filed August 14, 2026 · Our reading of the company's report
The latest report
The filing reflects a fundamental business contraction rather than a normal operating quarter: on July 17, 2026, Aterian sold substantially all historical revenue-generating assets and retained primarily Vremi, Xtava,…
The filing reflects a fundamental business contraction rather than a normal operating quarter: on July 17, 2026, Aterian sold substantially all historical revenue-generating assets and retained primarily Vremi, Xtava, and residual corporate activities. The transactions produced $25.0 million of aggregate gross proceeds and eliminated the MidCap debt facility, but management continues to identify substantial doubt about going-concern status. A single stockholder controls approximately 95% of fully diluted shares, while tariff, recall, leadership-transition, liquidity, and potential Nasdaq-delisting risks remain material.
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
The company received approximately $2.8 million of tariff refunds during the three months ended June 30, 2026, recorded as a reduction to cost of goods sold.
The July 17, 2026 transactions generated $25.0 million in aggregate gross proceeds before transaction expenses, adjustments, and debt settlements.
All outstanding indebtedness under the MidCap credit facility was repaid in full and the facility was terminated on July 17, 2026.
Management concluded that disclosure controls and procedures were effective as of June 30, 2026, with no material changes to internal control during the six months ended June 30, 2026.
Following the July 17, 2026 preferred-stock closing, David E. Lazar controls approximately 95% of the fully diluted share capitalization, creating severe dilution and concentrated voting control for existing common stockholders.
The company sold substantially all historical assets and operating operations on July 17, 2026; remaining operations primarily consist of Vremi, Xtava, and residual corporate activities. Management states future viability depends on an unproven strategic Pivot or a suitable strategic transaction.
Management states there is substantial doubt about the company’s ability to continue as a going concern. Although the July 17 transactions generated $25.0 million of aggregate gross proceeds, the filing provides no assurance that remaining capital will sustain long-term operations or that the revised strategy will generate positive cash flows.
Section 122 tariffs expired on July 24, 2026, but possible replacement tariffs under Sections 301 and 232 have no statutory rate ceiling or fixed expiration and could increase cost of goods sold for the retained brands.
The company disclosed a voluntary recall of approximately 195,000 PurSteam steamers and agreed to a $100,000 settlement on May 13, 2026 related to the associated litigation.
Nasdaq’s proposed $5.0 million minimum market-value-of-listed-securities rule is currently stayed, but if reinstated and market value remains below $5.0 million for 30 consecutive business days, the company could face immediate suspension and delisting without a cure period.
No quantitative revenue, EPS, margin, or cash-flow guidance was provided in the filing. The outlook is centered on an unproven strategic Pivot following the July 17, 2026 sale of substantially all historical operating assets.
Aterian, Inc. reported a drastic decrease in revenue of 72% in Q1 2026 compared to Q1 2025, falling to $18 thousand primarily due to reduced consumer demand amid macroeconomic pressures. The company is undergoing…
Aterian describes itself as an e-commerce-first consumer products company selling owned brands primarily through Amazon. The 2025 10-K discloses a board-approved strategic alternatives process (Dec 8, 2025), substantial…
Aterian reported Q2 2025 revenue of $19.462M, down 30.5% year-over-year (Q2 2024: $27.984M) but up versus Q1 2025 ($15.0M). Gross margin compressed to 54.3% (Q2 2024: 60.4%), operating loss widened to $4.505M (Q2 2024:…
Aterian reported Q3 net revenue of $26,239,000 and GAAP net loss per share of $(0.25). Revenue declined materially year-over-year (from $39,668,000 in Q3 2023) but gross margin and operating performance improved driven…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.